Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema (unspecified eye)
ICD-10 E10.3399 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema (unspecified eye).
E10.3399 refers to a specific condition in which a patient has Type 1 diabetes mellitus accompanied by moderate nonproliferative diabetic retinopathy (NPDR) without macular edema in an unspecified eye. Type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, resulting from damage to the retinal blood vessels due to prolonged hyperglycemia. Moderate NPDR is identified by the presence of microaneurysms, retinal hemorrhages, and exudates, but without the presence of macular edema, which is a more severe form of retinopathy. Management of this condition typically involves strict glycemic control, regular eye examinations, and possibly insulin therapy to maintain HbA1c levels within target ranges. The absence of macular edema indicates a better prognosis compared to proliferative diabetic retinopathy, but ongoing monitoring is essential to prevent progression.
Detailed records of diabetes management, including insulin regimens and HbA1c levels.
Patients presenting with uncontrolled diabetes and complications such as retinopathy.
Ensure comprehensive documentation of diabetes management and complications.
Detailed eye examination findings, including retinal imaging results.
Patients undergoing routine eye exams for diabetic retinopathy screening.
Document the absence of macular edema and the specific findings of NPDR.
Used during routine eye exams for diabetic retinopathy screening.
Document findings of the eye exam, including retinopathy severity.
Ophthalmologists should ensure detailed documentation of retinal findings.
Moderate NPDR indicates a higher risk of progression to more severe forms of retinopathy, making regular monitoring and management critical.
Patients should have regular eye exams at least annually, or more frequently if retinopathy is present or if diabetes is poorly controlled.
